|
CXADR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.746200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.293600E-01 |
| Normal-vs-Stage2 |
3.514600E-01 |
| Normal-vs-Stage3 |
6.355200E-01 |
| Normal-vs-Stage4 |
3.321400E-01 |
| Stage1-vs-Stage2 |
1.580600E-01 |
| Stage1-vs-Stage3 |
4.285200E-01 |
| Stage1-vs-Stage4 |
2.364400E-01 |
| Stage2-vs-Stage3 |
8.185200E-01 |
| Stage2-vs-Stage4 |
9.570600E-01 |
| Stage3-vs-Stage4 |
8.285400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.736000E-01 |
| Normal-vs-AfricanAmerican |
9.964000E-01 |
| Normal-vs-Asian |
2.484800E-03 |
| Caucasian-vs-AfricanAmerican |
5.379200E-01 |
| Caucasian-vs-Asian |
4.276000E-03 |
| AfricanAmerican-vs-Asian |
7.780200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.173200E-01 |
| Normal-vs-Female |
1.038400E-01 |
| Male-vs-Female |
1.270400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.368200E-01 |
| Normal-vs-Extreme_Weight |
9.468400E-01 |
| Normal-vs-Obese |
1.958430E-01 |
| Normal-vs-Extreme_Obese |
1.026580E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.696800E-01 |
| Normal_Weight-vs-Obese |
1.027010E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.922200E-01 |
| Extreme_Weight-vs-Obese |
2.573600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.413000E-01 |
| Obese-vs-Extreme_Obese |
1.536400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.220600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.091410E-01 |
| Normal-vs-Age(61-80Yrs) |
8.520400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.219000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.629600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.602400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.696800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.012390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.221610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.448600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.420970E-01 |
| Normal-VS-Type2 PRCC |
7.160400E-03 |
| Normal-VS-KIRP CIMP |
4.080200E-01 |
| Normal-VS-Unclassified PRCC |
8.259800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.593770E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.544000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.407600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.341600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.062100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.675200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.920600E-03 |
| Normal-vs-N1 |
8.122000E-01 |
| Normal-vs-N2 |
1.727610E-01 |
| N0-vs-N1 |
8.952100E-02 |
| N0-vs-N2 |
4.396200E-02 |
| N1-vs-N2 |
4.311200E-01 |
|
|
